Genome Sequencing in Newborns May Identify Life-Threatening Disorders Missed by Traditional Tests: Study Shows

Written By :  Dr. Bhumika Maikhuri
Published On 2025-10-11 03:00 GMT   |   Update On 2025-10-11 09:21 GMT
Advertisement

A recent study published in Nature Medicine has revealed that adding genomic sequencing to Australia's standard newborn blood screening could dramatically improve early diagnosis and treatment for hundreds of severe childhood conditions.

The BabyScreen+ study demonstrated that using genomic sequencing, which maps a baby’s entire genetic code, could expand screening to detect hundreds of serious, treatable disorders. The test, using the same blood sample already collected for standard screening, returned results within 14 days.

Advertisement

In the pilot study, 1,000 newborns in Victoria were screened for changes in 605 genes linked to early-onset, severe, and treatable conditions. The genomic testing, conducted separately from the standard screening, required additional parental consent. Researchers found that 16 babies had a high likelihood of a genetic condition, yet only one was identified through the traditional heel-prick test.

One powerful case was that of baby Giselle, diagnosed at seven weeks with the life-threatening immune disorder hemophagocytic lymphohistiocytosis (HLH). “We went from thinking we had a healthy baby to the real possibility she might die,” said her mother, Scarlett. A successful bone marrow transplant, with Scarlett as the donor, saved Giselle’s life.

Lead researcher Professor Zornitza Stark said, “Newborn screening for rare conditions is one of the most effective public health interventions,” emphasizing how genomic screening vastly expands the range of detectable diseases. Associate Professor Sebastian Lunke added that while the technology offers lifelong benefits, it raises concerns around privacy, cost, data storage, and consent.

With 99.5% of parents in the study supporting universal access to the testing, the study's findings pave the way for broader adoption.

Reference: Lunke, S., Downie, L., Caruana, J. et al. Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening study. Nat Med (2025). https://doi.org/10.1038/s41591-025-03986-z

Full View
Tags:    
Article Source : Nature Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News